C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/13 (2006.01) A61K 39/395 (2006.01) A61P 35/00 (2006.01) C07K 16/28 (2006.01) C07K 16/30 (2006.01) C12N 5/16 (2006.01) C12P 21/08 (2006.01) G01N 33/574 (2006.01) C07K 14/715 (2006.01)
Patent
CA 2597171
The invention provides characterization of the disease and cancer-associated antigen, OSM-R.beta. The invention also provides modulators of OSM-R.beta, including a family of monoclonal antibodies that bind to antigen OSM-R.beta, and methods of diagnosing and treating various human cancers and diseases associated with OSM-R.beta.
Cette invention concerne la caractérisation de l'antigène OSM-R.béta associé à la maladie et au cancer. Cette invention concerne également des modulateurs de OSM-R.béta, y compris une famille d'anticorps monoclonaux qui se lient à l'antigène OSM-R.béta ainsi que des méthodes de diagnostic et de traitement de différents cancers et maladies de l'homme associés à OSM-R.béta.
Mather Jennie P.
Roberts Penelope E.
Borden Ladner Gervais Llp
Raven Biotechnologies Inc.
LandOfFree
Antibodies to oncostatin m receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies to oncostatin m receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to oncostatin m receptor will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1638525